Efficacy of Gonadotropin-Releasing Hormone Agonist and an Extended-Interval Dosing Regimen in the Treatment of Patients with Adenomyosis and Endometriosis

Publisher： Karger

E-ISSN： 1423-002x|69|2|73-77

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.69, Iss.2, 2009-11, pp. : 73-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Gonadotropin-Releasing Hormone Agonist Treatment upon Angiogenesis in Uterine Leiomyoma

By  

Gynecologic and Obstetric Investigation, Vol. 52, Iss. 2, 2001-09 ,pp. : 108-113

Karger

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone Agonist Reduces Aromatase Cytochrome P450 and Cyclooxygenase-2 in Ovarian Endometrioma and Eutopic Endometrium of Patients with Endometriosis

By  

Gynecologic and Obstetric Investigation, Vol. 68, Iss. 2, 2009-04 ,pp. : 73-81

Karger

Access to resources Recommend Favorite

Efficacy of Every-Other-Day Administration of Conjugated Equine Estrogen and Medroxyprogesterone Acetate on Gonadotropin-Releasing Hormone Agonists Treatment in Women with Endometriosis

By  

Gynecologic and Obstetric Investigation, Vol. 52, Iss. 4, 2001-11 ,pp. : 217-222

Karger

Access to resources Recommend Favorite

Effects of Add-Back Therapy on Bone Mineral Density and Pyridinium Crosslinks in Patients with Endometriosis Treated with Gonadotropin-Releasing Hormone Agonists

By  

Gynecologic and Obstetric Investigation, Vol. 47, Iss. 1, 1999-01 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

Increased Natural Killer Cell Activities in Patients Treated with Gonadotropin Releasing Hormone Agonist

By  

Gynecologic and Obstetric Investigation, Vol. 48, Iss. 1, 1999-07 ,pp. : 66-68

Karger

Access to resources Recommend Favorite